← Back to patent-cliff list
CAS 2087975-91-3
sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate
Codes: RISE-002
Application context (from source-drug indications)
OsteoporosisColecalciferol/Risedronate SodiumPostmenopausal osteoporosisColecalciferol/Risedronate SodiumPaget's diseaseRisedronate Sodium HydratePostmenopausal osteoporosisRisedronate Sodium HydrateOsteoporosisRisedronate Sodium HydrateGlucocorticoid-induced osteoporosisRisedronate Sodium HydrateMetabolic bone diseaseRisedronate Sodium HydrateLung cancerRisedronate Sodium Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Colecalciferol/Risedronate Sodium | Tier C — Watch / trade | - |
| Risedronate Sodium Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(pyridin-3-yl)acetic acid→sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate
2-(pyridin-3-yl)acetic acid→sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.